AIM: To examine the effects of an Ilex paraguariensis (Ip) extract on postischemic alterations derived from 20 min of global ischemia and 30 min of reperfusion. METHODS: Isolated rat hearts were treated 10 min before ischemia and the first 10 min of reperfusion with Ip 30 microg/ml. In other hearts, chelerythrine (1 microM), a protein kinase C blocker, or l(G)-nitro l-arginine methyl ester (l-NAME), a nitric oxide synthase inhibitor, were administered prior to Ip infusion. Left ventricular developed pressure (LVDP), +dP/dt(max), -dP/dt(max), and left ventricular end diastolic pressure (LVEDP) were used to assess myocardial function. Thiobarbituric acid reactive substances (TBARS) were measured. RESULTS: Ip treatment produced an improvement of postichemic recovery (LVDP=96+/-8%; +dP/dt(max)=95+/-10%; -dP/dt(max)=90+/-12% vs. 57+/-6%, 53+/-6% and 57+/-8%, respectively, in untreated hearts) and an attenuation of the increase of LVEDP and TBARS content. Chelerythrine did not modify and l-NAME abolished the protection induced by Ip. CONCLUSIONS: These data are the first demonstration that Ip extract attenuates the myocardial dysfunction provoked by ischemia and reperfusion and that this cardioprotection involves a diminution of oxidative damage through a nitric oxide-dependent mechanism.
AIM: To examine the effects of an Ilex paraguariensis (Ip) extract on postischemic alterations derived from 20 min of global ischemia and 30 min of reperfusion. METHODS: Isolated rat hearts were treated 10 min before ischemia and the first 10 min of reperfusion with Ip 30 microg/ml. In other hearts, chelerythrine (1 microM), a protein kinase C blocker, or l(G)-nitro l-arginine methyl ester (l-NAME), a nitric oxide synthase inhibitor, were administered prior to Ip infusion. Left ventricular developed pressure (LVDP), +dP/dt(max), -dP/dt(max), and left ventricular end diastolic pressure (LVEDP) were used to assess myocardial function. Thiobarbituric acid reactive substances (TBARS) were measured. RESULTS:Ip treatment produced an improvement of postichemic recovery (LVDP=96+/-8%; +dP/dt(max)=95+/-10%; -dP/dt(max)=90+/-12% vs. 57+/-6%, 53+/-6% and 57+/-8%, respectively, in untreated hearts) and an attenuation of the increase of LVEDP and TBARS content. Chelerythrine did not modify and l-NAME abolished the protection induced by Ip. CONCLUSIONS: These data are the first demonstration that Ip extract attenuates the myocardial dysfunction provoked by ischemia and reperfusion and that this cardioprotection involves a diminution of oxidative damage through a nitric oxide-dependent mechanism.
Authors: María Laura Pérez; Mónica Mariana Collavino; Pedro Alfonso Sansberro; Luis Amado Mroginski; Ernestina Galdeano Journal: World J Microbiol Biotechnol Date: 2016-02-29 Impact factor: 3.312
Authors: A Łukomska; K Jakubczyk; D Maciejewska; I Baranowska-Bosiacka; K Janda; M Goschorska; D Chlubek; B Bosiacka; I Gutowska Journal: Biol Trace Elem Res Date: 2015-03-17 Impact factor: 3.738
Authors: Natalia Pachura; Robert Kupczyński; Jordan Sycz; Agata Kuklińska; Anna Zwyrzykowska-Wodzińska; Katarzyna Wińska; Aleksandra Owczarek; Piotr Kuropka; Renata Nowaczyk; Przemysław Bąbelewski; Antoni Szumny Journal: Foods Date: 2021-12-25
Authors: P Zielinsky; A L Piccoli; J L Manica; L H Nicoloso; H Menezes; A Busato; M R Moraes; J Silva; L Bender; P Pizzato; L Aita; M Alievi; I Vian; L Almeida Journal: J Perinatol Date: 2009-07-30 Impact factor: 2.521
Authors: Yasmin E Lopera; Juliana Fantinelli; Luisa F González Arbeláez; Benjamín Rojano; José Luis Ríos; Guillermo Schinella; Susana Mosca Journal: Evid Based Complement Alternat Med Date: 2013-02-06 Impact factor: 2.629
Authors: D T A da Veiga; R Bringhenti; R Copes; E Tatsch; R N Moresco; F V Comim; M O Premaor Journal: Braz J Med Biol Res Date: 2018-04-19 Impact factor: 2.590